<DOC>
	<DOCNO>NCT02129322</DOCNO>
	<brief_summary>The study design investigate effect adjuvant therapy Sorafenib , Oxaliplatin S-1 prevent tumor recurrence hepatocellular carcinoma liver transplantation</brief_summary>
	<brief_title>Effect Adjuvant Therapy Sorafenib , Oxaliplatin S-1</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>hepatocellular carcinoma liver transplantation Major organ ( heart , lung brain ) function normal Any active infectious process The presence clinically confirm extrahepatic metastasis Postoperative dysfunction organ</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>